Introduction
Acute ischemic renal injury is a frequent clinical problem associated with high mortality (1) . In recent years, there have been significant insights into the pathophysiology of renal ischemia (2, 3) . Important vascular and hematologic factors involved include endothelins (4), nitric oxide (5) , leukocytes (6) , and growth factors (7) . Nevertheless, there are still no accepted specific treatments for renal ischemia, and there has been little improvement in survival in the last 40 years (8) .
Ischemic injury to tissues triggers a complex series of metabolic disturbances, often culminating in cell death. Furthermore, the importance of sublethal injury to tubular cells as it relates to the phenotype of cell death is increasingly appreciated (9) . Many intracellular mediators have been implicated in altering the balance between apoptosis and necrosis. These include ATP depletion; cell pH and calcium; and phospholipid messengers such as ceramide, phospholipase A2, and reactive oxygen species. The relative importance of these mediators is tissue specific but their induction of apoptosis proceeds primarily via the intrinsic mitochondrial pathway.
Data showing the importance of nucleotide depletion in initiating cell death stems largely from cell culture studies. Using well-established models of mitochondrial poisons or anoxia, these studies have correlated the severity of ATP depletion with the phenotype of cell death (10) . Mild to moderate ATP depletion triggers apoptosis while severe depletion results in necrosis. These studies fall well within the accepted paradigm of apoptosis having an absolute requirement for ATP. However, the impact of ischemiainduced changes in other nucleotides has not been extensively investigated (11) .
Recently, we have documented remarkable changes in cellular GTP levels during chemical anoxia in vitro and renal ischemia in vivo (12) . The decline in GTP levels paralleled ATP levels and was as severe. We further developed models of selective nucleotide depletion of graded severity and correlated the induction of apoptosis in LLC-PK1 renal epithelial cells solely with the depletion of GTP. ATP depletion of any severity, if unaccompanied by GTP depletion, resulted only in necrosis.
Here we extend our in vitro findings to evaluate the role of GTP in apoptosis during renal ischemia in vivo. Because we have documented previously profound depletion of GTP during renal artery clamp in the rat (12) , we investigated whether enhancing GTP levels during reperfusion alters the induction of apoptosis in postischemic kidneys. Our results show that renal GTP levels are important determinants of the phenotype of cell death after renal ischemia. Furthermore, they underscore the critical role of apoptosis as a determinant of the functional injury to the kidneys after an ischemic insult.
Ischemic injury to the kidney is characterized in part by nucleotide depletion and tubular cell death in the form of necrosis or apoptosis. Recently, we linked anoxia-induced apoptosis in renal cell cultures specifically to the depletion of GTP. We therefore hypothesized that enhancing GTP repletion in vivo might protect function by reducing apoptosis in postischemic tubules. Male C57 black mice (the "I" group of animals) underwent bilateral renal artery clamp for 32 minutes to induce ischemia and then received either normal saline ("NS") or guanosine ("G"). After 1 hour of reperfusion, renal GTP levels in NS/I were reduced to nearly half of those in sham operated mice, whereas these levels were nearly unchanged in G/I mice. Morphologic examination of tubular injury revealed no significant differences between the two groups. However, there was a significant reduction in the number of apoptotic tubular cells in the medulla in the G/I group as compared with the NS/I group. At 24 hours, creatinine was significantly elevated in the NS/I group, compared to the G/I group. We conclude that guanosine protects against renal ischemic injury by replenishing GTP stores and preventing tubular apoptosis.
Research Involving Animals and Human Beings. Guanosine (Sigma Chemical Co., St. Louis, Missouri, USA), 30 mg/kg in 0.9% NaCl, or an equal volume of 0.9% NaCl was administered via intraperitoneal injection. The dose of guanosine was based on the in vivo use of nucleosides from cancer literature (13) . Male C57 black mice weighing 15-25 g and Sprague-Dawley rats weighing 180-220 g (Harlan, Indianapolis, Indiana, USA) were anesthetized with intraperitoneal sodium pentobarbital (50-70 mg/kg) and placed on a homeothermic table to maintain core body temperature at 37°C. Both renal pedicles were occluded via a midline incision for 32 minutes (14) . Sham surgery consisted of an identical procedure with the exception of application of the microaneurysm clamps. Creatinine was determined by standard picric acid reaction in serum obtained from the tail vein or by cardiac puncture.
Light microscopy. Twenty-four hours after surgery, kidneys were perfusion fixed in situ with 4% paraformaldehyde. Kidneys were paraffin embedded, sectioned at 4 µm, and stained using hematoxylin and eosin (H&E). The percentage of tubules in the cortex and outer medulla that showed epithelial necrosis with luminal necrotic debris and tubular dilation were each quantified as follows: 0%, <10%, 10-25%, 26-75%, and >75%. The estimates were performed by a blinded observer on coded sections (three to four sections per kidney and 10 to 12 fields per section) (15) .
Fluorescence microscopy. A Zeiss confocal microscope (LSM 510; Carl Zeiss Inc., Thornwood, New York, USA), equipped with ultraviolet, argon, and helium lasers, was used. Pieces from the in situ fixed kidneys were preserved in 30% sucrose before 10-µm frozen sections were obtained. Some sections were stained with FITC-phalloidin (for evaluation of actin cytoskeleton architecture and as a marker for proximal tubules) and 4′,6-diamidine-2-phenylindole dihydrochloride (DAPI), a nuclear stain (Molecular Probes Inc., Eugene, Oregon, USA). Other sections were also costained with a rabbit polyclonal anti-human Tamm-Horsfall protein Ab (THP; Biogenesis Inc., Kingston, New Hampshire, USA) and a goat anti-rabbit Cy5-conjugated secondary Ab (Amersham Pharmacia Biotech, Piscataway, New Jersey, USA). This was used as a marker for Henle's loop.
Finally, separate sections were stained with TUNEL reagent (Promega Corp., Madison, Wisconsin, USA) and DAPI for in situ apoptosis detection. In brief, 10-µm frozen sections were treated with 20 µg/ml proteinase K and then incubated in a nucleotide mixture containing fluorescein-12-dUTP and terminal transferase (TdT). Positive controls were pretreated with 1 U/ml DNase, and negative controls were incubated without TdT. TUNEL-positive nuclei were expressed as a percentage of total nuclei (DAPI positive) per field. Six to eight fields per section and two to three sections per kidney were examined in each experiment.
In some experiments, TUNEL-positive nuclei were expressed as a percentage of total nuclei of a particular tubular segment. This was done by labeling 5-µm sections with TUNEL reagent and a directly contiguous 5-µm section from the same tissue with phalloidin and anti-THP Ab. Overlay of the two sections allowed the localization of TUNEL-positive nuclei to various tubular segments.
Nucleotide extraction. Kidney tissue obtained 1 hour after sham surgery or ischemia with cutting forceps precooled in liquid nitrogen was crushed under liquid nitrogen and resuspended in 30% ice-cold acetonitrile and centrifuged at 16,000 g for 10 minutes at -20°C. The supernatant fraction, kept on ice, was gassed with N 2 for 30 minutes to evaporate acetonitrile, and the nucleotides were assayed by HPLC as described in detail previously (12) . The pellet's protein content was analyzed with Coomassie blue assay (Pierce Chemical Co., Rockford, Illinois, USA).
Plasma guanosine levels. Blood was collected into a chilled stopping solution: 26 µM erythro-9-(2hydroxy-3-nonyl) adenine hydrochloride, 100 µM dipyridamole, 4mM EDTA, 2 µg/ml indomethacin, and 100 U/ml heparin. The plasma was separated by centrifugation and the proteins precipitated with 10% trichloroacetic acid. The supernatant was washed with
Figure 2
Effects of guanosine on renal nucleotide levels during reperfusion. Values are means ± SE. Mice received normal saline (NS, n = 5) or guanosine (G, n = 5) 30 mg/kg intraperitoneally, 2 hours before 32-minute bilateral renal ischemia (I) or sham surgery. Renal tissues were obtained from each kidney 1 hour after surgery and processed for nucleotide determination (*P < 0.02, when GTP in NS/I was compared with GTP in G/I).
Figure 1
Effects of intraperitoneal guanosine on plasma guanosine levels. Animals received 30 mg/kg guanosine intraperitoneally 2 hours before bilateral renal ischemia/reperfusion. Blood was collected at various time points and plasma guanosine levels determined by HPLC as detailed in Methods. Values are means ± SE (n = 3).
tert-butyl-ether and the organic layer discarded. The sample was filtered through a cyano-bonded solidphase extraction cartridge and assayed by HPLC using established protocols (16) .
Studies with LLC-PK1 cells. A4.8 clones of LLC-PK1 porcine proximal tubule cells were grown in 5% CO 2 at 37°C in DMEM with 10% FBS (Sigma Chemical Co.) and 5 mM glucose (referred to as regular medium). For chemical anoxia, 0.1 µM antimycin A was used in depleted media (DMEM without amino acids, glucose, or serum). Nucleotide extraction and measurements were done as described previously (12) . Cell death was determined using a Zeiss confocal microscope. Both adherent and floating cells were visualized after staining with Hoechst 33342 and propidium iodide, as described previously (12) . Cell viability was based on the criteria of trypan blue exclusion and cell adherence as described by others (10) .
Statistics. Creatinine, guanosine, and nucleotide levels are expressed as means plus or minus SE. ANOVA was used to determine if differences among mean values reached statistical significance. Student t test was used for comparisons between groups. Bonferonni adjustment was used for multiple comparisons. Fisher's exact test was used to determine if differences in histological parameters were significantly different.
Results
Effect of intraperitoneal guanosine on plasma guanosine levels. We first examined the time course of changes in plasma guanosine levels following an intraperitoneal guanosine administration in mice subjected to bilateral ischemia/reperfusion. As shown in Figure 1 , there was a significant increase in plasma guanosine that peaked 2 hours after guanosine administration. Three to 7 hours after the intraperitoneal injection, levels were significantly lower than those at 2 hours but still slightly higher than baseline. Thus, guanosine was administered 2 hours before surgery in all subsequent experiments except when stated otherwise.
Effects of intraperitoneal guanosine on renal nucleotide levels during reperfusion. We have shown previously that renal GTP and ATP levels fall to less than 10% of control during renal artery clamp exceeding 20 minutes (12) . After 6 to 8 hours of reperfusion, GTP and ATP normalized to preischemia levels. Furthermore, the decline in GTP levels during ischemia could not be prevented by guanosine supplementation (data not shown). Therefore, we investigated the effects of guanosine on GTP at an early time point during reperfusion. In the control kidneys, ATP was 18 ± 3 pmol/µg protein and GTP was 6 ± 2 pmol/µg protein.
As shown in Figure 2 , renal GTP levels were above 92% of control at 1 hour of reperfusion in the guanosine/ischemia mice (G/I) compared with 56% in normal saline/ischemia mice (NS/I). Furthermore, guanosine supplementation did not affect ATP levels significantly (44% in G/I versus 36% in NS/I). Thus, guanosine selectively increased GTP levels to near baseline values after only 1 hour of reperfusion. Guanosine had no significant effects on GTP or ATP in the sham kidneys. Similar results were obtained in rats: in control sham kidneys, ATP was 28 ± 4 pmol/µg protein and GTP 8 ± 2 pmol/µg protein. Guanosine increased GTP after 1 hour reperfusion to 107% of control compared with 65% in the NS/I (P < 0.01). ATP levels were 49% in the G/I group versus 58% in the NS/I (P = NS).
Effects of guanosine and enhanced GTP recovery on renal histology at 24 hours. Histological sections of kidneys from NS-treated mice (NS/I group) removed 24 hours after ischemia showed extensive tubular necrosis, tubular dilation, and cast formation in the outer medulla ( Figure 3 ). Sections from the guanosine-treated mice (G/I group) had similar histological features. Quantitation of these changes showed no significant differ- ences between these groups (Table 1 ). In addition, staining with phalloidin demonstrated comparable disruption and thinning of apical actin rim between the two groups. The sham surgery group showed a wellformed, thick, and continuous actin rim ( Figure 3 ). Thus, guanosine and enhanced GTP recovery after ischemia did not have a significant effect on the morphologic consequences of renal ischemia in this mouse model. The histology and actin architecture of the sham group that received guanosine were normal and indistinguishable from the NS-treated sham group.
Similar changes were seen in rat kidneys. The majority of sections of outer medulla from both the NS/I and G/I rats showed evidence of tubular necrosis in >75% of tubules examined. The apical actin rim also showed comparable thinning and disruption in both groups (data not shown).
Effects of guanosine and enhanced GTP recovery on renal cell apoptosis at 24 hours. At 24 hours after ischemia, guanosine had a remarkable effect on the occurrence of apoptosis in renal tissues. As shown in Figure 4 , kidneys from mice in the NS/I group showed extensive TUNEL-positive staining (Figure 4c) , predominantly in the outer medulla. In contrast, kidneys from mice in the G/I group had very little TUNELpositive staining (Figure 4d ). Furthermore, because the TUNEL stain can occasionally be nonspecific, we examined nuclear morphology with DAPI staining at higher magnification (×60). In Figure 4e , nuclei from the NS/I group showed heavy staining and condensation of chromatin.
The inset in Figure 4e shows ×120 magnification of a single nucleus. Fragmentation of chromatin into several smaller bodies is seen, a hallmark of apoptosis. Figure 4f is a ×60 magnification of nuclei from G/I mice. They do not show condensation and stain very faintly with DAPI.
In addition, we confirmed the presence of apoptotic nuclei in the NS/I group by high-magnification (×100) light microscopy of H&E-stained tissues. As shown in Figure 5 , a and b, very few if any apoptotic nuclei were observed in the G/I group. In contrast, multiple apoptotic nuclei with classic condensation and fragmentation can be seen in the NS/I group (Figure 5 , c-f). Elec- tron microscopic examination of tissues from the NS/I group clearly identified two types of nuclei in addition to normal ones: apoptotic nuclei ( Figure 5g ) and necrotic ones (Figure 5h ). Thus, the apoptosis found by TUNEL was confirmed by fluorescence, light, and electron microscopic criteria. The distribution of TUNEL-positive staining between outer medulla and cortex in the four groups is shown in Figure 6 . The highest TUNEL-positive staining was in the medulla of the NS/I group and represented 28% of all nuclei stained in this region. In the G/I group, the number of TUNEL-positive nuclei was reduced significantly to 3%. There was less TUNEL positivity in the cortex of the NS/I group (8%), but this was still reduced in the G/I group to less than 2%. Similar results were observed in rats. The NS/I group showed 33% TUNELpositive nuclei in the medulla. This was reduced in the G/I group to less than 5%. There was minimal cortical TUNEL positivity (<2%) in all groups.
Distribution of TUNEL-positive nuclei among various medullary structures. We next examined the distribution of TUNEL-positive nuclei in the NS/I group among various medullary segments of the nephron. As detailed in Methods, this was done by overlay of TUNEL-stained sections with directly contiguous sections stained with phalloidin and anti-THP Ab (17) . As shown in Figure 7 , TUNEL-positive nuclei (Figure 7a ) and proximal tubules, distal tubules, as well as loop segments (Figure 7b ), could easily be overlaid to yield a composite picture (Figure 7c) showing the TUNEL distribution among various segments. Figure 7d shows a quantitative estimate of the TUNEL distribution obtained by counting ten fields similar to that shown in Figure 7c . On average, there was no difference between proximal, distal, and loop (THP + ) segments, with each having 26-29% of their nuclei TUNEL positive. Of note is the presence of about 44% TUNEL-positive nuclei in tubular lumens (normalized to all luminal nuclei). Few TUNEL-positive nuclei were noted in interstitial and vascular structures.
Effects of guanosine and enhanced renal GTP levels on renal function at 24 hours. The results presented above show that guanosine and increased GTP levels did not alter the histological findings at 24 hours but did reduce significantly medullary apoptosis. To test if this reduction in apoptosis had any impact on function, we measured serum creatinine in all groups at 24 hours. As shown in Figure 8 , the NS/I group had a mean creatinine of 2.1 ± 0.3 mg/dl. This was significantly reduced to 0.76 ± 0.12 mg/dl in the G/I group. In fact, the creatinine in the G/I group was comparable to that of the two sham groups. Guanosine and enhanced GTP levels had a similar protective effect in the rat: at 24 hours, creatinine was 3.2 ± 0.3 mg/dl in the NS/I group compared with 1.4 ± 0.2 mg/dl in the G/I group (n = 3, P < 0.01).
We further examined the window of efficacy of guanosine. We found that guanosine was most protec- tive when given 2 hours before ischemia. Mean creatinine was no different than in the control postischemic group when guanosine was given 4 or 8 hours before ischemia or 4 or 8 hours after ischemia. When guanosine was given at the time of ischemia or 2 hours after ischemia, the improvement in mean creatinine did not reach statistical significance. Peak guanosine levels occur 2 to 3 hours after an intraperitoneal injection (Figure 1 ), coinciding well with the enhanced GTP levels observed 1 hour after ischemia (3 hours after guanosine administration).
Effects of guanosine on nucleotide content, cell viability, and apoptosis after chemical anoxia in LLC-PK1 cells. Because of the cellular complexity of kidney tissues, we investigated if the reported changes in nucleotides and cell death can be reproduced in tubular cells in culture. For this purpose, we used the well-characterized LLC-PK1 proximal tubular cell line to model the effects of guanosine. Resting ATP and GTP levels were 36 ± 4 pmol/µg and 8 ± 2 pmol/µg protein, respectively (n = 20). The addition of up to 200 µM guanosine for 2 hours increased ATP to 40 ± 3 pmol/µg and GTP to 9 ± 2 pmol/µg protein (n = 5). Both changes were not statistically significant.
Next we investigated the effects of guanosine on nucleotide recovery after antimycin A-induced chemical anoxia. As shown in Figure 9a , 45 minutes' exposure to 0.1 µM antimycin A in depleted media reduced ATP to 5% ± 2% and GTP to 8% ± 2% of control levels. After 2 hours' recovery in regular media, ATP was 33% ± 3% and GTP was 49% ± 4% of control values. When 200 µM guanosine was included in the recovery medium for 2 hours, ATP was 35% ± 2% and GTP was 88% ± 5% of control (Figure 9b ). Thus, guanosine enhanced early selective GTP recovery after chemical anoxia.
We then quantitated cell viability after chemical anoxia and recovery for 24 hours. The presence of guanosine significantly increased cell viability at 24 hours: viability was 70% ± 8% in the guanosine-treated group as compared with 44% ± 6% in the control group (P < 0.02). As shown in Figure 9 , c and d, the increase in viability in the guanosine group primarily was due to a reduction in apoptotic cell death. Indeed, the guanosine-treated group showed less than 10% apoptosis at 8, 12, and 24 hours as compared with 40% in the control group (the representative fields shown in Figure 9 are from a 24-hour time point). Neither group showed any significant necrosis at these three time points as evidenced by exclusion of propidium iodide. Thus, guanosine supplementation reduces apoptosis and increases viability after in vitro chemical anoxia in LLC-PK1 proximal tubular cells.
Discussion
In this article, we extend our findings relating apoptosis and GTP depletion in cell culture to the in vivo ischemia setting. Indeed, our results in both mice and rats show that guanosine selectively repletes renal GTP levels after 1 hour of reperfusion. This early increase in GTP is accompanied by a significant reduction in medullary apoptosis and a remarkable protective effect on GFR. Therefore, these results introduce two important concepts to be discussed. First is the relationship of GTP levels to apoptosis and second is the relationship of apoptosis to renal function.
The depletion of guanine nucleotides has been implicated in the induction of apoptosis in anoxic cells in culture (12) and in settings other than anoxia or ischemia (18, 19) . The exact mechanism is unknown, but two hypotheses have been proposed: first is the small size of the GTP pools compared with ATP pools (20, 21) . In most cells, the GTP/ATP ratio is around 1:5, and thus even minor reductions in GTP could be rate limiting for nucleic acid synthesis and hence trigger apoptosis. The second mechanism proposes that GTP depletion could alter the activation states of GTPases of the Ras superfamily (18, 22) . Most members of this family are oncogenes and their inactivation has been linked to apoptosis (23) .
Our results in mice and rats are in remarkable agreement with our in vitro findings and strongly implicate GTP depletion in renal tubular apoptosis. However, the complexity of in vivo renal ischemia imposes significant caution to the proposal of a direct link between GTP and apoptosis. For example, the reported GTP levels are average numbers from both cortex and medulla. Thus, the exact GTP changes in these two regions could not be dissected further. In addition, the presence of multiple cell types in these regions also imposes some restriction on our results. However, tubular cells are far more abundant than other cell types, and this justifies our assumption that the reported levels predominantly represent tubular GTP. Furthermore, we were able to reproduce the changes in GTP (and apoptosis) in LLC-PK1 proximal tubular cells in culture. Thus, the reported changes in nucleotides in renal tissues most likely reflect events in tubular cells. Improvements in the sampling technique for GTP measurements will allow a better evaluation of the role of this nucleotide in cortical versus medullary regions.
Recent studies have reported a protective effect of guanosine against neuronal hypoxic injury in culture (24, 25) . This beneficial effect was ascribed to an enhancement in ATP production. Our in vivo and in vitro studies do not support such a role for guanosine in renal tubular cells. After guanosine administration, only GTP levels were increased with minimal or no effect on ATP levels. Selective effects of guanosine on GTP as opposed to a nonselective increase in all nucleotides could be related to the doses of guanosine used or cellspecific differences in purine metabolic pathways.
Another degree of caution is imposed by our limited knowledge of possible direct effects of guanosine unrelated to nucleotide production. These could include hemodynamic, vascular, or anti-inflammatory properties. However, unlike adenosine, guanosine has no known receptors or second messenger cascades. It is taken up by specific transporters into cells and then proceeds via the salvage pathway to generate guanine nucleotides (26) . This pathway is catalyzed by the ratelimiting enzyme hypoxanthine phosphoribosyl transferase (HPRT). Studies in HPRT-null mice will uncover possible direct effects of guanosine. These mice cannot synthesize GTP from guanosine and therefore will be useful to probe for direct effects of guanosine (27) . Nevertheless, the histological findings in the G/I group revealed morphological damage similar to that seen in the NS/I group. These data and those in LLC-PK1 cells argue against significant beneficial hemodynamic or anti-inflammatory properties of guanosine. They also underscore the difference in apoptosis as the main underlying mechanism for the improved function.
Our confidence in the TUNEL assay as a reporter of apoptosis relies on two facts. First is the confirmation of apoptosis by morphological criteria. Indeed, condensation and fragmentation of nuclear chromatin remains the gold standard for the diagnosis of apoptosis. Second, the lack of TUNEL positivity in the G/I group (despite extensive necrosis comparable to that seen in NS/I group) argues against nonspecific or necrotic readings of the TUNEL assay (28) . Thus, both the TUNEL assay and nuclear morphology suggest that guanosine significantly reduced medullary apoptosis after ischemia-reperfusion injury.
Apoptosis has been reported after ischemia and its inhibition often leads to improved function in many organ systems (29) (30) (31) (32) (33) . The pathophysiology of this phenomenon is more easily understood in settings such as stroke or myocardial infarction. This relates to preservation of neuronal and cardiac tissue mass, which in
Figure 9
Effects of guanosine on nucleotide levels and apoptosis after chemical anoxia recovery in LLC-PK1 cells. Values are means ± SE. (a) LLC-PK1 cells were treated for 45 minutes with 0.1 µM antimycin A in depleted media followed by recovery for 2 hours. Nucleotides were measured at 45 minutes of depletion (n = 7) and at 2 hours of recovery (n = 6). (b) Cells were treated identically except for the addition of 200 µM guanosine to the recovery medium (n = 6). (c and d) Representative fields of confocal microscopic images of LLC-PK1 cells at 24 hours after recovery from chemical anoxia. Cells were costained with Hoechst 33342 and propidium iodide as detailed in Methods. In c, cells recovered in regular media. Apoptotic features such as condensation and fragmentation of chromatin is seen in most cells in the field. In d, cells recovered in the presence of 200 µM guanosine. Most nuclei showed normal morphology, and only few had apoptotic features. turn affects function directly. In the kidneys, the link between inhibition of apoptosis and the improved GFR is less obvious. A recent study proposed that apoptosis is proinflammatory and thus detrimental to function (30) . Our histological findings do not support such an interpretation. In fact, a lack of correlation between histological evidence of injury and renal function has been found in both human acute renal failure (34, 35) and in animal models of renal injury (36) . It is possible that prevention of apoptotic death in nearly 30% of medullary tubular cells confers a protective effect on overall tubular integrity and nephron function.
In conclusion, we report a novel finding regarding the protective effect of guanosine against renal ischemic injury in vivo. Our results show that guanosine selectively increases GTP and has no significant effects on ATP pools. Thus, this protective effect is likely secondary to enhanced GTP levels leading to reduced medullary programmed cell death. Our study highlights the importance of cellular GTP levels as targets for therapeutic intervention. It also proposes guanosine as a potential tool to manipulate GTP levels in vivo and alter the outcome of ischemic injury to the kidneys.
